ESMO26 Reviews Three Randomized Trials in Muscle-Invasive Bladder Cancer
Audio narration · Coming soon
At the ESMO26 conference, Tom Powles discusses findings from three randomized trials focused on muscle-invasive bladder cancer (MIBC). This examination highlights recent advancements and research in oncology related to bladder cancer treatment.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews